AbbVie Inc. (ABBV)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, AbbVie Inc. reported revenue of $61.16B, up 8.6% from the prior year. The company was profitable, with a net margin of 6.9%.
Key ratios (FY2025)
24.6%
Operating margin
6.9%
Net margin
+8.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B | $45.80B | $33.27B | $32.75B | $28.22B | $25.64B |
| Cost of Revenue | $18.20B | $16.90B | $20.41B | $17.41B | $17.45B | $15.39B | $7.44B | $7.72B | $7.04B | $5.83B |
| Operating Income | $15.07B | $9.14B | $12.76B | $18.12B | $17.92B | $11.36B | $12.98B | $6.38B | $9.54B | $9.34B |
| Net Income | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B | $4.62B | $7.88B | $5.69B | $5.31B | $5.95B |
| EPS (Diluted) | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 | $2.72 | $5.28 | $3.66 | $3.30 | $3.63 |
| Total Assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.56B | $89.11B | $59.35B | $70.79B | $66.10B |
| Shareholders' Equity | -$3.27B | $3.33B | $10.36B | $17.25B | $15.41B | $13.08B | -$8.17B | -$8.45B | $5.10B | $4.64B |
| Cash & Equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B | $8.45B | $39.92B | $7.29B | $9.30B | $5.10B |
| Operating Cash Flow | $19.03B | $18.81B | $22.84B | $24.94B | $22.78B | $17.59B | $13.32B | $13.43B | $9.96B | — |
| Capital Expenditures | $1.21B | $974.00M | $777.00M | $695.00M | $787.00M | $798.00M | $552.00M | $638.00M | $529.00M | $479.00M |
| Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.78B | 1.78B | 1.67B | 1.48B | 1.55B | 1.60B | 1.63B |
| Dividends Per Share | $6.65 | $6.29 | $5.99 | $5.71 | $5.31 | $4.84 | $4.39 | $3.95 | $2.63 | $2.35 |